AIM ImmunoTech Stock (AMEX: AIM) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 0 / 283.18K |
Day Range | - - - |
52 Wk Range | 0.31 - 0.75 |
Market Cap | $21.60M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | AMEX |
RSI | 47 |
Short Interest | 0.91% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of AIM ImmunoTech (AMEX:AIM) through any online brokerage.
Other companies in AIM ImmunoTech’s space includes: Vincerx Pharma (NASDAQ:VINC), Lumos Pharma (NASDAQ:LUMO), Evaxion Biotech (NASDAQ:EVAX), Nanoviricides (AMEX:NNVC) and Viracta Therapeutics (NASDAQ:VIRX).
There is no analysis for AIM ImmunoTech.
There is no analysis for AIM ImmunoTech to provide a consensus price target.
The stock price for AIM ImmunoTech (AMEX: AIM) is $0.38 last updated July 5, 2024 at 4:31 PM EDT.
There are no upcoming dividends for AIM ImmunoTech.
AIM ImmunoTech’s Q2 earnings are confirmed for Tuesday, August 13, 2024.
There is no upcoming split for AIM ImmunoTech.
AIM ImmunoTech is in the Health Care sector and Biotechnology industry. They are listed on the AMEX.